ESC Premium Access

Resistant hypertension: stimulating the baroreflex when drugs have failed.

Topic: CHF - Non pharmacological treatment
Organised by Charité Medical School, supported with an educational grant by CVRx

Congress Presentation

About the speaker

Professor Peter W De Leeuw

Maastricht (Netherlands (The))
3 presentations
0 follower

3 more presentations in this session

Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.

Speaker: Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

Speaker: Professor A. Pathak (Monaco, MC)

Thumbnail

Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?

Speaker: Professor C. Butter (Bernau bei Berlin, DE)

Thumbnail

Access the full session

Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension

Speakers: Professor P. De Leeuw, Professor S. Anker, Professor F. Zannad, Professor A. Pathak, Professor C. Butter
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb